Improving Outcomes in IPF Through a Patient-Centered, Team-Based Approach
PROGRAM DESCRIPTION Idiopathic pulmonary fibrosis (IPF) is a rare and progressive fibrotic lung disease with a median survival of 2 ½ to 5 years, which is worse than most cancers. ...
Idiopathic pulmonary fibrosis (IPF) is a rare and progressive fibrotic lung disease with a median survival of 2 ½ to 5 years, which is worse than most cancers. With nonspecific signs and symptoms including dyspnea and cough, diagnosis is challenging and often delayed. While there is no cure, antifibrotic therapies can slow or halt disease progression and, along with supportive measures, improve patients' quality of life. During this Patient Caregiver Connection® Medical Crossfire®, a multidisciplinary panel of expert faculty will share their insights on early, differential diagnosis and discuss clinical practice guideline updates which include conditional recommendations for the antifibrotic therapies pirfenidone and nintedanib. Faculty will then elaborate on the need for a multidisciplinary ‘ABCDE’ approach to address not only the range of comorbidities associated with IPF, but to provide comfort care that assesses and focuses on individual patient needs. This activity is enhanced with a patient’s own story and perspective, from delays in diagnosis to daily challenges and advice for anyone burdened with a diagnosis of IPF.
After completing this activity, clinicians should be better able to:List strategies for confirming an IPF diagnosis, including the utility of high-resolution computed tomography and surgical lung biopsyDistinguish idiopathic from non-idiopathic forms by applying appropriate diagnostic testing, such as high-resolution CT scanning, to characterize distribution of fibrosis and inflammationApply current guidelines and new clinical evidence to develop a patient-centered, team approach plan for patients with IPFDiscuss new evidence and the status of emerging treatments for patients with IPFDescribe strategies to engage patients and facilitate a multidisciplinary approach to the management of IPF and associated comorbidities
I'm interested in this
Share with others
Write the first review
Share with others